Locke Lord advised Table Talk Pies on the transaction, and Kirkland & Ellis advised Olympus Partners. Leading bakery manufacturer, Rise Baking Company announced the acquisition of...
You must be a Standard 1 Year member to access this content.
Lazard acted as TPI’s financial advisor. Goodwin Procter LLP acted as TPI’s legal advisor and Sullivan & Cromwell LLP acted as Oaktree’s legal advisor. TPI Composites,...
You must be a Standard 1 Year member to access this content.
Goodwin advised Seagen on the deal. Nurix Therapeutics, Inc. (Nasdaq: NRIX) announced that it has entered into a multi-year, multi-target strategic collaboration agreement with Seagen Inc....
You must be a Standard 1 Year member to access this content.
Goodwin advised Nimbus Therapeutics on the financing. Nimbus Therapeutics announced its $210 million private financing to advance its next wave of tech-enabled small molecule medicines. The...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini advised ImmunityBio, and Goodwin advised the placement agent. ImmunityBio, Inc. (NASDAQ: IBRX) announced that it has executed financing to provide further working capital and support...
You must be a Standard 1 Year member to access this content.
Goodwin advised BrainStorm on the offering, and Ellenoff Grossman advised the placement agent. BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI) announced its registered direct offering of 4,054,055...
You must be a Standard 1 Year member to access this content.
Goodwin advised Akero Therapeutics on the offering, and Cooley advised the underwriter involved. Akero Therapeutics (Nasdaq: AKRO) announced the closing of its underwritten registered direct offering...
You must be a Standard 1 Year member to access this content.
Goodwin advised Honest Day’s Work on the deal. Latch, Inc. (NASDAQ: LTCH) announced that it has entered into a definitive agreement to acquire Honest Day’s Work...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised BridgeBio Pharma on the offering, and Latham & Watkins advised the underwriters involved. BridgeBio Pharma, Inc. announced the pricing on March 7, 2023 of...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Qualtrics International Inc. on the deal. Qualtrics International Inc. (NASDAQ: XM) announced its definitive agreement to be acquired by Silver Lake, in partnership...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised TPI Composites, Inc. on the deal. Davis Polk advised the representative of the initial purchasers and the counterparties to the capped call transactions...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Jefferies LLC as exclusive placement agent on the deal. ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, announced that it has executed financing...
You must be a Standard 1 Year member to access this content.
